Case File Banner 24

Switch Case: Potential Response to Ang-2 in Wet AMD

Show Description +

Many patients try a series of anti-VEGF agents before they finally find a treatment that allows extended duration that meaningful affects the burden of care. Join Ash Abbey, MD, as he shares the case of a wet AMD patient who, after 3 years of treatment on various therapies, finally found an option that allowed the patient to extend to a 12-week interval.

Posted: 8/30/2024

Keywords:

anti-VEGF

wet AMD

Season Three

Up Next


Roundtable: Navigating the Treatment Landscape, and a Look at the Pipeline

Ferhina Ali, MD; Ash Abbey, MD; and Scott Walter, MD, MSc,

Roundtable: When and How to Approach Using Newly Approved Anti-VEGF Agents

Priya Sharma Vakharia, MD; Joseph M. Coney, MD; and Yasha S. Modi, MD

Real-World Treatment-Naïve Case: Bilateral Wet AMD in a 92-Year-Old Patient

Priya Sharma Vakharia, MD, Joseph M. Coney, MD, and Jordan M. Graff, MD

Real-World Switch Case: Wet AMD Therapy in a Patient Averse to Injections

Priya Sharma Vakharia, MD, Joseph M. Coney, MD, and Jordan M. Graff, MD

Real-World Treatment-Naïve Case: Treating DME With a Dual-Inhibition Approach

Priya Sharma Vakharia, MD, Joseph M. Coney, MD, and Jordan M. Graff, MD

Real-World Step Therapy Case: A Challenging DME Patient

Priya Sharma Vakharia, MD, Joseph M. Coney, MD, and Jordan M. Graff, MD

Real-world Switch Case: Wet AMD Patient Who Relies on Family for Transportation

Priya Sharma Vakharia, MD, Joseph M. Coney, MD, and Jordan M. Graff, MD

Roundtable: Balancing Safety Concerns With Unmet Needs in Wet AMD and DME Therapy

Priya Sharma Vakharia, MD, Joseph M. Coney, MD, and Jordan M. Graff, MD

Switch Case: Potential Response to Ang-2 in Wet AMD

Many patients try a series of anti-VEGF agents before they finally find a treatment that allows extended duration that meaningful affects the burden of care. Join Ash Abbey, MD, as he shares the case of a wet AMD patient who, after 3 years of treatment on various therapies, finally found an option that allowed the patient to extend to a 12-week interval.

Posted: 8/30/2024

Keywords:

anti-VEGF

wet AMD

Season Three

Please log in to leave a comment.